On August 7, 2024, several board members of Novo Nordisk A/S reported purchasing shares: Kasim Kutay bought 83 ADRs for DKK 837.52 each, Maha Kutay bought 1,970 shares at various prices, and Choi Lai Christina Law purchased 2,000 ADRs at DKK 850.67 each. This filing reflects compliance with market abuse regulations.